1-3 of 3
Authors: Inder Kaul
Journal Article
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf015, https://doi.org/10.1093/ijnp/pyaf015
Published: 08 March 2025
Journal Article
SAFETY AND EFFICACY OF KARXT IN PATIENTS WITH SCHIZOPHRENIA IN THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EMERGENT TRIALS
International Journal of Neuropsychopharmacology, Volume 28, Issue Supplement_1, February 2025, Page i162, https://doi.org/10.1093/ijnp/pyae059.279
Published: 12 February 2025
Journal Article
EFFICACY OF KARXT ON NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA: AN ANALYSIS OF POOLED DATA FROM 3 TRIALS
International Journal of Neuropsychopharmacology, Volume 28, Issue Supplement_1, February 2025, Pages i358–i359, https://doi.org/10.1093/ijnp/pyae059.636
Published: 12 February 2025
